Published in Atherosclerosis on January 01, 2000
Platelets in inflammation and atherogenesis. J Clin Invest (2005) 4.10
A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med (2002) 2.75
Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood (2005) 1.78
Leukocyte-endothelial interactions in inflammation. J Cell Mol Med (2009) 1.51
Pathogenesis of atherosclerosis: A multifactorial process. Exp Clin Cardiol (2002) 1.31
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2011) 1.26
New Insights in the Immunobiology of IL-1 Family Members. Front Immunol (2013) 1.12
Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol (2014) 1.02
Inflammation and haemostasis. Biochem Med (Zagreb) (2012) 1.01
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun (2005) 0.96
Platelets in inflammation and atherogenesis. Front Immunol (2015) 0.94
Platelet decline as a predictor of brain injury in HIV infection. J Neurovirol (2011) 0.91
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care (2012) 0.88
Platelets in inflammation: regulation of leukocyte activities and vascular repair. Front Immunol (2015) 0.87
Pathways to acute humoral rejection. Am J Pathol (2004) 0.87
Contribution of blood platelets to vascular pathology in Alzheimer's disease. J Blood Med (2013) 0.85
The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects. PPAR Res (2008) 0.85
Alloantibody induced platelet responses in transplants: potent mediators in small packages. Hum Immunol (2012) 0.83
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. JACC Cardiovasc Imaging (2012) 0.83
Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis. Thromb Haemost (2014) 0.80
Effects of ethanol on the properties of platelets and endothelial cells in model experiments. World J Cardiol (2012) 0.77
Beyond Clotting: A Role of Platelets in CNS Repair? Front Cell Neurosci (2016) 0.75
Systemic inflammation affects reperfusion following transient cerebral ischaemia. Exp Neurol (2016) 0.75
Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease. ARYA Atheroscler (2015) 0.75
Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome. J Am Heart Assoc (2014) 0.75
Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients. Mediators Inflamm (2017) 0.75
Head and neck cancer. N Engl J Med (2001) 7.32
Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology (1998) 3.82
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet (1995) 3.76
Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J Virol (1983) 3.41
Sequencing of the 16S-23S spacer in a ribosomal RNA operon of Zea mays chloroplast DNA reveals two split tRNA genes. Cell (1981) 3.40
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the functions of these sequences. J Virol (1984) 3.09
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest (1996) 2.96
Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med (1996) 2.95
FDP-activation of yeast pyruvate kinase. Biochem Biophys Res Commun (1966) 2.40
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation (2001) 2.34
The structural biology of expression and function of tissue factor. Thromb Haemost (1991) 2.28
Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation (1996) 2.20
Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res (2001) 2.18
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med (1991) 2.10
Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci U S A (2000) 2.10
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J (2001) 2.06
The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res (1993) 2.05
Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation (1998) 1.95
Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem J (1985) 1.92
Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med (1997) 1.91
Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem (1994) 1.90
Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol (1997) 1.84
Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res (1996) 1.80
Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation (1996) 1.75
Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol (1998) 1.73
Managing diabetes in residential and nursing homes. BMJ (1998) 1.70
Donor-acceptor interaction and the peculiar structures of dications. J Am Chem Soc (1986) 1.67
Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation (1995) 1.66
Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv (2000) 1.65
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation (1998) 1.63
Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang (1998) 1.62
Vessel size and long-term outcome after coronary stent placement. Circulation (1998) 1.61
Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation. Circulation (2001) 1.61
Symposium--forensic psychiatry. Civil commitment and the danger mandate. Can Psychiatr Assoc J (1973) 1.60
Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med (2008) 1.60
Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia (2007) 1.58
PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol (2000) 1.56
Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation (2000) 1.56
Operator volume and outcome of patients undergoing coronary stent placement. J Am Coll Cardiol (1998) 1.56
Dissociation between coronary sinus and left atrial conduction in patients with atrial fibrillation and flutter. J Cardiovasc Electrophysiol (2001) 1.56
Civil commitment practices in 1977: troubled semantics and/or troubled psychiatry. Can Psychiatr Assoc J (1979) 1.55
A liver storage test for the assessment of vitamin A. Biochem J (1944) 1.55
Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol (2001) 1.55
Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut (1987) 1.54
A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J (1997) 1.53
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. J Thromb Haemost (2010) 1.52
Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods. J Clin Microbiol (2001) 1.49
Comparison of angiography and intravascular ultrasound for the assessment of lumen size after coronary stent placement: impact of dilation pressures. Cathet Cardiovasc Diagn (1997) 1.49
Allelotype of head and neck squamous cell carcinoma. Cancer Res (1994) 1.47
Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation (1997) 1.47
Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis. Thromb Haemost (2012) 1.45
Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Circulation (2000) 1.45
Evaluation of the dietary intake of homebound elderly and the feasibility of dietary supplementation. J Am Coll Nutr (1994) 1.45
Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci (2000) 1.44
A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. J Intern Med (2004) 1.43
Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel. J Thromb Haemost (2006) 1.43
Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility. Circ Res (2001) 1.42
P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents. Cardiology (2008) 1.42
New drugs for Alzheimer's disease. Br J Psychiatry (1999) 1.42
B-cell control region at the 5' end of a major histocompatibility complex class II gene: sequences and factors. Mol Cell Biol (1988) 1.41
Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. Cytotherapy (2004) 1.41
Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol (2001) 1.41
[Isolated myocardial noncompaction in childhood-case report and review of the literature]. Z Kardiol (2003) 1.40
Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res (1994) 1.40
G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis (2000) 1.39
Rh hemolytic disease of the newborn. Neonatal Netw (1989) 1.39
Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol (1996) 1.38
Distribution of angiographic measures of restenosis after drug-eluting stent implantation. Heart (2009) 1.38
Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. J Am Coll Cardiol (1999) 1.38
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res (1984) 1.38
Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis (2001) 1.36
Calcium fluxes in frog heart ventricles. Pflugers Arch (1969) 1.35
Analysis of catecholamine effects in single atrial trabeculae of the frog heart. Proc R Soc Lond B Biol Sci (1977) 1.31
Distribution and structure of vagal afferent intraganglionic laminar endings (IGLEs) in the rat gastrointestinal tract. Anat Embryol (Berl) (1997) 1.29
The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem (1993) 1.29
Purified polyoma virus medium T antigen has tyrosine-specific protein kinase activity but no significant phosphatidylinositol kinase activity. Mol Cell Biol (1986) 1.27
Role of nuclear factor-kappa B in atherogenesis. Exp Physiol (1997) 1.26
Aspects of androgen-dependent events as studied by antiandrogens. Recent Prog Horm Res (1970) 1.25
Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol (1999) 1.25
Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol (2001) 1.24
Restenosis after coronary placement of various stent types. Am J Cardiol (2001) 1.24
New civil commitment legislation. The relevance of commitment "criteria". Can J Psychiatry (1980) 1.23
Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res (1987) 1.23